SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-041036
Filing Date
2019-11-06
Accepted
2019-11-06 16:15:53
Documents
43
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20191106.htm 8-K 37629
2 EX-99.1 abio-ex991_6.htm EX-99.1 175522
3 EX-99.2 abio-ex992_113.htm EX-99.2 45312
4 GRAPHIC gd2uz1ymw5ks000009.jpg GRAPHIC 251736
5 GRAPHIC gd2uz1ymw5ks000002.jpg GRAPHIC 517883
6 GRAPHIC gd2uz1ymw5ks000033.jpg GRAPHIC 410870
7 GRAPHIC g0xeaxezps3s000001.jpg GRAPHIC 20861
8 GRAPHIC gd2uz1ymw5ks000023.jpg GRAPHIC 309968
9 GRAPHIC gd2uz1ymw5ks000036.jpg GRAPHIC 329801
10 GRAPHIC gd2uz1ymw5ks000027.jpg GRAPHIC 320962
11 GRAPHIC gd2uz1ymw5ks000013.jpg GRAPHIC 351558
12 GRAPHIC gd2uz1ymw5ks000030.jpg GRAPHIC 382032
13 GRAPHIC gd2uz1ymw5ks000011.jpg GRAPHIC 357066
14 GRAPHIC gd2uz1ymw5ks000010.jpg GRAPHIC 278741
15 GRAPHIC gd2uz1ymw5ks000037.jpg GRAPHIC 211896
16 GRAPHIC gd2uz1ymw5ks000003.jpg GRAPHIC 333522
17 GRAPHIC gd2uz1ymw5ks000012.jpg GRAPHIC 464348
18 GRAPHIC gd2uz1ymw5ks000007.jpg GRAPHIC 315983
19 GRAPHIC gd2uz1ymw5ks000029.jpg GRAPHIC 238363
20 GRAPHIC gd2uz1ymw5ks000032.jpg GRAPHIC 396810
21 GRAPHIC gd2uz1ymw5ks000004.jpg GRAPHIC 311516
22 GRAPHIC gd2uz1ymw5ks000025.jpg GRAPHIC 372119
23 GRAPHIC gd2uz1ymw5ks000008.jpg GRAPHIC 244056
24 GRAPHIC gd2uz1ymw5ks000014.jpg GRAPHIC 355336
25 GRAPHIC gd2uz1ymw5ks000034.jpg GRAPHIC 269430
26 GRAPHIC gd2uz1ymw5ks000015.jpg GRAPHIC 325807
27 GRAPHIC gd2uz1ymw5ks000024.jpg GRAPHIC 322117
28 GRAPHIC gd2uz1ymw5ks000001.jpg GRAPHIC 477057
29 GRAPHIC gd2uz1ymw5ks000026.jpg GRAPHIC 305812
30 GRAPHIC gd2uz1ymw5ks000039.jpg GRAPHIC 466711
31 GRAPHIC gd2uz1ymw5ks000028.jpg GRAPHIC 283223
32 GRAPHIC gd2uz1ymw5ks000006.jpg GRAPHIC 365378
33 GRAPHIC gd2uz1ymw5ks000038.jpg GRAPHIC 148574
34 GRAPHIC gd2uz1ymw5ks000005.jpg GRAPHIC 248476
35 GRAPHIC gd2uz1ymw5ks000035.jpg GRAPHIC 238907
36 GRAPHIC gd2uz1ymw5ks000016.jpg GRAPHIC 274263
37 GRAPHIC gd2uz1ymw5ks000020.jpg GRAPHIC 321278
38 GRAPHIC gd2uz1ymw5ks000017.jpg GRAPHIC 458140
39 GRAPHIC gd2uz1ymw5ks000031.jpg GRAPHIC 318518
40 GRAPHIC gd2uz1ymw5ks000021.jpg GRAPHIC 300555
41 GRAPHIC gd2uz1ymw5ks000019.jpg GRAPHIC 460991
42 GRAPHIC gd2uz1ymw5ks000022.jpg GRAPHIC 376581
43 GRAPHIC gd2uz1ymw5ks000018.jpg GRAPHIC 269138
  Complete submission text file 0001564590-19-041036.txt   18176144
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 191196484
SIC: 2835 In Vitro & In Vivo Diagnostic Substances